Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Arnold Chan

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Pharmacoepidemiology and Drug Safety|September 1, 2005
Signal detection in pharmacovigilance: empirical evaluation of data mining toolsK Arnold Chan, Manfred Hauben
Plos One|January 16, 2014
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.SSibel Ascioglu, K Arnold Chan
Rheumatic Diseases Clinics of North America|October 19, 2004
Pharmacoepidemiology and rheumatic disordersK Arnold Chan, Sonia Hernandez-Diaz
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 21, 2003
Cost-effectiveness analysis of interferon-alpha therapy in the treatment of chronic hepatitis B in TaiwanRaoh-Fang Pwu, K Arnold Chan
BMC Medical Research Methodology|August 21, 2008
Pooling overdispersed binomial data to estimate event rateYinong Young-Xu, K Arnold Chan
Frontiers in Pharmacology|February 13, 2026
Editorial: Advancement of RWD/RWE utilization for enhancing drug development and benefit/risk assessmentYoshiaki Uyama, Anick Bérard, K Arnold Chan
Pharmacoepidemiology and Drug Safety|September 24, 2004
Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitorsSusanna Jacobus, Sebastian Schneeweiss, K Arnold Chan
European Journal of Epidemiology|February 21, 2026
Re: Liu et al., "On the reported methodology in published TriNetX-based studies: an analysis of impossible index event designs"Sarah E Williford, K Arnold Chan, Jeffrey S Brown
Current Medical Research and Opinion|March 13, 2009
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburideDavid D Dore, John D Seeger, K Arnold Chan
Journal of Cancer|July 11, 2019
Intensive Care Unit Admission and Survival in Stage IV Cancer Patients with Septic Shock: A Population-Based Cohort StudyMeng-Rui Lee, Chao-Lun Lai, K Arnold Chan
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Pharmacoepidemiology and Drug Safety|September 1, 2005
Signal detection in pharmacovigilance: empirical evaluation of data mining toolsK Arnold Chan, Manfred Hauben
Plos One|January 16, 2014
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.SSibel Ascioglu, K Arnold Chan
Rheumatic Diseases Clinics of North America|October 19, 2004
Pharmacoepidemiology and rheumatic disordersK Arnold Chan, Sonia Hernandez-Diaz
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 21, 2003
Cost-effectiveness analysis of interferon-alpha therapy in the treatment of chronic hepatitis B in TaiwanRaoh-Fang Pwu, K Arnold Chan
BMC Medical Research Methodology|August 21, 2008
Pooling overdispersed binomial data to estimate event rateYinong Young-Xu, K Arnold Chan
Frontiers in Pharmacology|February 13, 2026
Editorial: Advancement of RWD/RWE utilization for enhancing drug development and benefit/risk assessmentYoshiaki Uyama, Anick Bérard, K Arnold Chan
Pharmacoepidemiology and Drug Safety|September 24, 2004
Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitorsSusanna Jacobus, Sebastian Schneeweiss, K Arnold Chan
European Journal of Epidemiology|February 21, 2026
Re: Liu et al., "On the reported methodology in published TriNetX-based studies: an analysis of impossible index event designs"Sarah E Williford, K Arnold Chan, Jeffrey S Brown
Current Medical Research and Opinion|March 13, 2009
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburideDavid D Dore, John D Seeger, K Arnold Chan
Journal of Cancer|July 11, 2019
Intensive Care Unit Admission and Survival in Stage IV Cancer Patients with Septic Shock: A Population-Based Cohort StudyMeng-Rui Lee, Chao-Lun Lai, K Arnold Chan
Pageof 14